MSig ‐C4 subtype exhibits a rich tumour microenvironment with increased IFN‐γ signalling and PD‐L1 expression, whereas C2, as a cold tumour, shows the lowest levels, highlighting the importance of subtype‐specific immunotherapy. This evidence concerns the gene CD274 and neoplasm.